Cell Therapeutics received "fast track" designation from the U.S. Food and Drug Administration for the treatment of certain types of cancer in women with a specific type of lung cancer.
Apr 11, 2007 (M2 EQUITYBITES via COMTEX News Network) -- Biopharmaceutical company Cell Therapeutics Inc (Nasdaq and MTAX: CTIC) announced on 10 April that its shareholders have approved the proposal to increase the number of authorised shares from 210m to 410m and to increase the number of authorised common shares from 200m to 400m.
Cell Therapeutics said that as of 15 April, the expected effective date of the one-for-four reverse stock split of common shares, the authorised common shares will total 100m with approximately 40m shares issued and outstanding.
-------------------- ......in Psychiatry circles it's known as a "warning sign" Posts: 1736 | From: Saint Louis | Registered: Jul 2005
| IP: Logged |